In particular, this study provides the first direct evidence of IGF-II’s role as a stage-specific component in the tumor angiogenic switch, the checkpoint at which a growing tumor acquires the capability to make its own blood vessels and acquire independent tridimensional growth features as typically observed during malignant transformation. This evidence concerns the gene IGF2 and neoplasm.